Pharmafile Logo
Pharmafocus logo
Advanced Search
hal-gatewood-_jbclosdsd4-unsplash

NICE publishes Final Appraisal Document for multiple myeloma drug

April 25, 2023
Medical Communications

The National Institute for Health and Care Excellence (NICE) has submitted a Final Appraisal Document (FAD) for the use of …

News
robina-weermeijer-so1l3jsdd3y-unsplash_2

AstraZeneca and Ionis share positive results from phase 3 trial for eplontersen

April 25, 2023
Medical Communications

AstraZeneca and Ionis have announced positive results from their phase 3 NEURO-TTRansform trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy …

News

National Institute for Health and Care Excellence recommends Darzalex® (daratumumab) with bortezomib and dexamethasone for routine use on the NHS as treatment for multiple myeloma

April 24, 2023
Business Services

High Wycombe, 24 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson are pleased to announce that the …

News
Press release

Sphere Fluidics begins work with partners on 3DSecret program to investigate mechanisms of metastasis in cancer

April 24, 2023
Business Services

Cambridge, UK, 24th April 2023: Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, …

News
Press release

Incyte Announces European Commission Approval of Opzelura® (ruxolitinib) Cream for the Treatment of Non-Segmental Vitiligo with Facial Involvement in Adults and Adolescents

April 24, 2023
Business Services

WILMINGTON, Del. – April 20, 2023 – Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has granted a marketing …

News
Press release

Janssen Marks First Approval Worldwide for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) with EC Authorisation for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations

April 24, 2023
Business Services

BEERSE, Belgium, 21 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission …

News
Press release

NICE gives green light to ibrutinib plus venetoclax as first-line treatment option for chronic lymphocytic leukaemia

April 24, 2023
Business Services

High Wycombe, 21 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson is pleased to announce that the …

News
Press release
national-cancer-institute-9k4fglw6efq-unsplash

NICE recommends treatment combination for advanced leukaemia

April 24, 2023
Medical Communications

The National Institute for Health and Care Excellence (NICE) has recommended Janssen’s imbruvica (ibrutinib) alongside venetoclax as a treatment option …

News
mufid-majnun-cm1au42fnrg-unsplash_3

Sanofi offers hepatitis A vaccine for UK children

April 24, 2023
Medical Communications

Sanofi has introduced a hepatitis A vaccine for children aged between one to 15 years old in the UK. The …

News
towfiqu-barbhuiya-hn2hqoalbck-unsplash_1

AbbVie shares results from phase 3 trial for atogepant migraine treatment

April 24, 2023
Research and Development

AbbVie has shared positive results from its phase 3 ELEVATE study, which assessed atogepant for the preventative treatment of episodic …

News
markus-spiske-hvsr_cvecvi-unsplash

Aptar and Healint announce collaboration on CNS and immune system conditions management

April 24, 2023
Medical Communications

AI healthcare company Healint and Software as a Medical Device (SaMD) expert Aptar Digital Health have announced a collaboration aiming …

News

RetinAI and Boehringer Ingelheim partner over AI treatments for geographic atrophy

April 21, 2023
Medical Communications

Swiss data management software company RetinAI and US-based Boehringer Ingelheim have announced a partnership to improve patient outcomes in geographic …

News

FDA awards clearance to Meridian Bioscience for Curian Shiga Toxin assay

April 21, 2023
Medical Communications

Meridian Bioscience, a US-based diagnostic testing solutions provider, has announced that the FDA has given clearance for its new Curian …

News

Breye Therapeutics Strengthens Management Team and Board

April 20, 2023
Business Services

Copenhagen, Denmark, 20 April 2023 – Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing novel oral therapies for retinal …

News
Press release
solen-feyissa-xfnfmlnpwdo-unsplash

Johnson & Johnson warns of dangers of Benadryl TikTok challenge

April 20, 2023
Medical Communications

Following the death of a 13-year-old boy who took part in an online “challenge” to take a large amount of …

News
charles-deloye-2roumsg9rnw-unsplash

Eli Lilly partners with Ivy Tech Community College for scholarship programme

April 20, 2023
Medical Communications

Eli Lilly and Ivy Tech Community College, Indiana, US, have announced a new scholarship programme, known as Lilly Scholars @ …

News

Trade union Unite calls for GSK staff walkouts over pay increase disputes

April 20, 2023
Manufacturing and Production

UK-based trade union Unite is pushing for staff walkouts at several GSK manufacturing sites due to disputes regarding pay increases. …

News
christina-victoria-craft-zhys6xn7sue-unsplash_5

PANTHERx Rare announces release of treatment for rare stable Wilson Disease

April 20, 2023
Sales and Marketing

US-based rare medicines pharmacy PANTHERx Rare has announced the launch of Cuvrior, a treatment for stable Wilson Disease in adults …

News

Elsevier launches EmBiology to deliver the unparalleled insights into biological activities that accelerate drug discovery

April 19, 2023
Business Services

New York, April 19, 2023 – Elsevier, a leader in global information analytics, has launched EmBiology, a research tool that …

News
Press release

Veeva MedTech Clinical Trials Report Signals Significant Opportunity to Improve Data Delivery and Quality

April 19, 2023
Business Services

BARCELONA, Spain — 19 Apr. 2023 — Veeva Systems (NYSE: VEEV) today released its first-ever report examining global trends in …

News
Press release
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026